Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06411353 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Blood Flow Conditions and Sounds in AVFs

Study acronym: APOLLO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jan 2028 to Feb 2028
    • Start date changed from estimate of Jul 2025 to Mar 1, 2025
    • Site details revised
    v5
  2. Primary and study completion dates: Jun 2027 to Jan 2028
    • Start date: Jan 2025 to Jul 2025
    v4
  3. Start date: Jul 2024 to Jan 2025
    • Site details revised
    v3
  4. Study description expanded, about 4 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective non-pharmacological interventional study aimed at investigating the relationship between the blood flow condition and the arteriovenous fistula (AVF) sound, with the ultimate aim of predicting the AVF clinical, in patients with end-stage renal disease (ESRD) who require the creation of a vascular access for extracorporeal circulation.
Trial Details
NCT Number NCT06411353
Lead Sponsor Mario Negri Institute for Pharmacological Research
Conditions
(from sponsor)		 End Stage Renal Disease
Related terms Arteriovenous Fistula, Constriction, Pathologic, Kidney Failure, Chronic
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov